Dolutegravir
ATC J05AJ03 · 10 markets · 64 records
AU 11 records · 2 strengths
- 50 mgtabletDovatoJuluca、JULUCA dolutegravir (as sodium) 50 mg/ rilpivirine (as hydrochloride) 25 mg tablet bottle、Tivicay、Triumeq、TRIUMEQ dolutegravir (as sodium) 50 mg/abacavir (as sulfate) 600 mg/lamivudine 300 mg tablet bottle
Records without a stated strength · 1 Dovato、Juluca、Tivicay、Tivicay PD、Triumeq
US 8 records · 4 strengths
- 50 mgtabletDovatoJuluca、Tivicay、Triumeq
- 5 mgtabletTivicay PD
- 10 mgtabletTivicay
- 25 mgtabletTivicay
GB 8 records · 4 strengths
CA 7 records · 2 strengths
ES 7 records · 3 strengths
- 50 mgtabletDovatoJuluca、Tivicay、Triumeq
- 5 mgtabletTIVICAY DISPERSABLESTRIUMEQ DISPERSABLES
- 10 mgtabletTivicay
TW 4 records · 2 strengths
- 50 mgtabletTivicay汰威凱膜衣錠50毫克
Records without a stated strength · 1 Dovato、Juluca、Triumeq、三恩美膜衣錠、洛瓦梭膜衣錠、滋若愷膜衣錠
EU 4 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Dovato、Juluca、Tivicay、Triumeq
CN 3 records · 2 strengths
- 50 mgtablet特威凯多替拉韦
- 5 mgtabletManufacturer: ViiV HealthcareBV
HK 3 records · 1 strengths
Records without a stated strength · 1 Dovato、Tivicay、Triumeq
MX 1 records · 1 strengths
- 50 mgtabletTivicay PD
| Strength / form / release | US | GB | CA | AU | CN | ES | MX | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|---|
| 50 mg tablet | Dovato Juluca Tivicay+1Triumeq | Dovato Juluca Tivicay+1Triumeq | Dovato Juluca PMS-DOLUTEGRAVIR | Dovato Juluca JULUCA dolutegravir (as sodium) 50 mg/ rilpivirine (as hydrochloride) 25 mg tablet bottle | 特威凯多替拉韦 | Dovato Juluca Tivicay+1Triumeq | Tivicay PD | Tivicay 汰威凱膜衣錠50毫克 | ||
| 5 mg tablet | Tivicay PD | Tivicay Triumeq | Tivicay | Manufacturer: ViiV HealthcareBV | TIVICAY DISPERSABLES TRIUMEQ DISPERSABLES | |||||
| 10 mg tablet | Tivicay | Tivicay | Tivicay | |||||||
| 25 mg tablet | Tivicay | Tivicay | ||||||||
unknown | Dovato Juluca Tivicay | Dovato Tivicay Triumeq | Dovato Juluca Tivicay+1Triumeq | |||||||
tablet | Dovato Juluca Triumeq |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in TW and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en TW que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 TW 有记录(未在本表显示)。 另有 1 個規格/劑型僅在 TW 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.